Stock screenerAll disclosures →
EDGAR →
ONMD
Conviction 4HealthcareScan · Mon, Aug 10, 2026ONMD$0.6655+6.57%
ResistanceSupportVol 14Insider buyVol MA14 3.65M
May 11May 28Jun 16Jul 6Jul 23Aug 10
Price0.6655
Change+6.57%
Gap+6.08%
Rel volume0.03×
Avg volume2.59M
Avg $ vol1.76M
SMA 200.6739
SMA 500.6700
SMA 2000.9982
Price vs 50-0.68%
Price vs 200-33.33%
MA stackbearish
50/200 cross—
Supertrendup · 0.5517
RSI (14)49
MACD hist-0.00
MACD crossbear · 1d
Stoch %K / %D39 / 33
ADX (14)17
+DI / −DI21 / 17
RSI divergence—
MACD divergence—
ATR %+12.94%
ADR %12.73%
52w high3.14
52w low0.4520
From 52w high-78.81%
Above 52w low+47.23%
New 52w highNo
SqueezeOn · 8d
Bollinger width28.83%
%B0.46
Donchian pos39.41%
Donchian high0.8274
Donchian low0.5602
AVWAP (52w high)1.33
vs AVWAP high-49.81%
AVWAP (52w low)1.50
vs AVWAP low-55.51%
OBV trendFlat
Chaikin MF (20)-0.03
Today vs 20d0.03×
Avg vol (14d)3.65M
Avg vol (20d)2.59M
Avg $ vol (20d)1.76M
Market cap36.23M
RS 3m (vs SPY)-41.82%
RS 6m (vs SPY)-35.06%
RS line new highNo
Trend template1/8
Technical rank23.7
1 week-12.34%
1 month-12.66%
3 months-34.75%
6 months-8.85%
1 year+36.37%
YTD-45.45%
P/E-12.93
P/B-8.88
P/S26.66
P/FCF-4.82
EPS-0.0600
Div yield—
ROE68.67%
ROA-185.87%
Debt/Eq-0.25
Current0.27
EV/EBITDA-3.85
Gross margin-37.01%
Net margin-206.11%
Rev growth111.35%
EPS growth72.35%
Price target—
Target upside—
Analyst rating—
Institutional—
Ent. value37.01M
Revenue96K
Net income-2.45M
Gross profit-380K
Free cash flow-7.52M
IndustrySERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH
ExchangeNasdaq
Shares out54.43M
Employees23
ListedWed, Nov 8, 2023
Free float19.1M
Float %37.4%
Short interest345.5K
Days to cover2.8d
Short volume26.9%
Squeeze score17 / 100
Next earnings—
EPS forecast—
Last EPS vs est—
Last surprise—
Setup gradeD
Conviction4 / 100
Pattern quality—
Tech rank23.7 / 100
Group rank86 / 100 · Leading
Status laneNo active setup
Setup direction—
Pattern family
Resistance0.7987
Support0.4900
Days since event—
Candle confirm—
News sentiment—
Financials as of Tue, Mar 31, 2026 · quarterly.
Congress activity
Disclosed STOCK Act trades in ONMD
No recent disclosed trades by Congress in ONMD. STOCK Act filings can lag the trade by up to 45 days.
Insider activity
SEC Form 4 transactions in ONMD · 6 buys
| Insider | Side | Shares | Value | Traded | Filed |
|---|---|---|---|---|---|
Kosasa Thomas Director · Common Stock · 2026-07-30 | Buy | 1.45M | $1000K | 2026-07-30 | 2026-08-07 |
Kosasa Thomas Director · Common Stock · 2026-05-18 | Buy | 268.82K | $250K | 2026-05-18 | 2026-05-20 |
Kosasa Thomas Director · Common Stock · 2026-04-23 | Buy | 280.9K | $250K | 2026-04-23 | 2026-04-24 |
Yu Jeffrey Chief Medical Officer · Common Stock · 2026-04-01 | Buy | 903.61K | $750K | 2026-04-01 | 2026-04-24 |
Yu Jeffrey Chief Medical Officer · Common Stock · 2026-04-01 | Other | — | — | 2026-04-01 | 2026-04-24 |
Yu Jeffrey Chief Medical Officer · Common Stock · 2026-04-01 | Grant | 219.43K | $182K | 2026-04-01 | 2026-04-24 |
Kosasa Thomas Director · Common Stock · 2026-02-06 | Buy | 595.24K | $500K | 2026-02-06 | 2026-04-24 |
SEC filings
EDGAR filings in ONMD · 6 recent
Get daily signals & real-time alerts.
StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.
Start free — 14-day full access →Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.